Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis.
Lean SC, Derricott H, Jones RL, Heazell AEP. · 2017
Read Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis. by Lean SC, Derricott H, Jones RL, Heazell AEP. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5645107.txt.
Introduction
Lean and co-authors pooled study data on pregnancy risks at older maternal ages. Their systematic review and meta-analysis appeared in PLoS ONE. Advanced maternal age means age 35 or older. The team searched six databases and trial sources. They kept cohort and case-control studies. The final pool held 75 studies.
Stillbirth risk rose clearly with older age. The authors report an odds ratio near 1.75. Risks also rose for growth restriction. Neonatal death and intensive care admission rose too. Gestational diabetes became more common. These links were not explained by other illness. Fertility treatment use did not explain them either. The authors propose placental problems as a cause. They call for direct prospective tests.
Catalog record
| CREATOR | Lean SC, Derricott H, Jones RL, Heazell AEP. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis By Samantha C Lean, Hayley Derricott, Rebecca L Jones, Alexander E P Heazell, Zulfiqar A Bhutta Published in: PLoS ONE DOI: 10.1371/journal.pone.0186287 ABSTRACT Abstract Background Advanced maternal age (AMA; ≥35 years) is an increasing trend and is reported to be associated with various pregnancy complications. Objective To determine the risk of stillbirth and other adverse pregnancy outcomes in women of AMA. Search strategy Embase, Medline (Ovid), Cochrane Database of Systematic Reviews, ClinicalTrials.gov, LILACS and conference proceedings were searched from ≥2000. Selection criteria Cohort and case-control studies reporting data on one or more co-primary outcomes (stillbirth or fetal growth restriction (FGR)) and/or secondary outcomes in mothers ≥35 years and <35 years. Data collection and analysis The effect of age on pregnancy outcome was investigated by random effects meta-analysis and meta-regression. Stillbirth rates were correlated to rates of maternal diabetes, obesity, hypertension and use of assisted reproductive therapies (ART). Main results Out of 1940 identified titles; 63 cohort studies and 12 case-control studies were included in the meta-analysis. AMA increased the risk of stillbirth (OR 1.75, 95%CI 1.62 to 1.89) with a population attributable risk of 4.7%. Similar trends were seen for risks of FGR, neonatal death, NICU unit admission restriction and GDM. The relationship between AMA and stillbirth was not related to maternal morbidity or ART. Conclusions Stillbirth risk increases with increasing maternal age. This is not wholly explained by maternal co-morbidities and use of ART. We propose that placental dysfunction may mediate adverse pregnancy outcome in AMA. Further prospective studies are needed to directly test this hypothesis. INTRODUCTION Advanced maternal age (AMA) is defined as childbearing in a woman over 35 years of age and is a growing trend within high-income countries [1] In 2013, 20% of births in England and Wales were to women aged 35 years or over and 4% to women ≥40 years compared to 6% and 1% respectively in 1980 [2] This trend is most commonly attributed to older primigravid women who delay childbearing by lifestyle choice or due to underlying subfertility, but also includes multiparous women continuing childbearing [3] Women in both groups have benefited from advancements in assisted reproductive technologies (ART). Although changes in social-economic circumstances and developments in ART have driven a shift towards childbearing later in life, this new trend potentially creates a clinical risk. AMA is reported to be associated with a range of pregnancy complications including: fetal growth restriction (FGR), preeclampsia (PE), placental abruption, pre-term birth (PTB) and stillbirth by a series of epidemiological studies [4–8] and importantly these increased risks appeared to be independent of maternal co-morbidities [9–11] Furthermore, systematic reviews and meta-analyses have demonstrated that AMA is associated with an increased risk of Caesarean birth [12] and that AMA is a risk factor for stillbirth [13] However, these latter studies have been limited by a lack of data regarding the causation of stillbirth in AMA pregnancies and have considered stillbirth in isolation. A structured review of pregnancy risks in women ≥45 years found increased rates of pre-existing hypertension and pregnancy complications, such as gestational diabetes mellitus (GDM), gestational hypertension and PE, all of which may predispose to stillbirth [14] Presently, the majority of stillbirths in high-income countries are related to placental dysfunction [15] Therefore, further studies are needed to examine the relationship between AMA and adverse pregnancy outcomes that are related to placental dysfunction to consider the underlying cause(s) for the reported increased risk of stillbirth in women of AMA. Objectives This systematic review’s objective is primarily to examine the strength of association between AMA and stillbirth and, secondarily, whether AMA is also associated with other pregnancy complications suggestive of placental dysfunction (e.g. FGR) that may explain this relationship. Furthermore, this review will evaluate the impact of maternal co-morbidities (obesity, diabetes and hypertension) and use of assisted reproductive techniques (ART) on stillbirth rates in AMA. METHODS Information sources, search strategy and eligibility criteria A systematic review and meta-analysis were conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and Meta-Analysis of Observational Studies in Epidemiology Group (MOOSE) criteria [16] Literature searches were conducted in MEDLINE (Ovid), EMBASE, ClinicalTrials.gov and LILACS and the Cochrane Database of Systematic Reviews using the search terms “maternal age”, “advanced”, “pregnancy” and “outcome” combined. The search was restricted to publication year ≥2000, full text and English language articles (including foreign language articles pre-translated by publisher). Foreign language articles were not included as translation services were unavailable. The search strategy can be found in the appendix. In addition, reference lists from included original papers and review articles were searched to identify further relevant studies. Additional searches were conducted to identify published perinatal mortality reviews (e.g. Confidential Enquiries into Stillbirths, National Review of Perinatal Mortality). Data extraction Observational studies using case control and cohort designs that reported one or more of the pre-specified primary and/or secondary outcomes for maternal age <35 (control) and ≥35 years (AMA) populations were included. Primary outcomes were stillbirth (according to individual study gestational age cut off) and fetal growth restriction (FGR) defined as birthweight below 5th centile adjusted for gestational age [17] Secondary outcomes were neonatal death (NND), small for gestation age (SGA; defined as a birthweight below 10th centile adjusted for gestational age or related definitions specified by authors), neonatal intensive care unit (NICU) admissions and neonatal acidosis (umbilical artery pH <7.0–7.2), preeclampsia (blood pressure ≥140/90 with significant proteinuria or as classified by authors where definition was not provided), placental abruption (classified by authors), preterm birth (PTB) <37 weeks gestation and gestational diabetes mellitus (GDM). Where authors stated different definitions of outcomes, data were re-classified in line with definitions stated (e.g. if authors defined FGR as <10th Centile this was re-classified as SGA in these analyses). Where definitions of classifications were not stated, authors’ classifications were accepted. Where possible, extracted data was sub-divided by parity (primiparous and multiparous mothers). Where reported, data regarding the frequency of maternal co-morbidities (obesity, hypertension and diabetes) and use of ART were extracted. Duplicate studies were removed and the papers were excluded if they: were case reports, were restricted to multiple pregnancies or did not separate data from multiple pregnancies from singletons, primarily reported the success rates of assisted reproductive technologies or pre-existing medical conditions as a primary outcome, focused on chromosomal abnormalities or substance abuse, relevant data could not be extracted or were review papers. Reports on rising Cesarean section rates with AMA were not included as a systematic review was recently conducted on this topic [12] The initial search was conducted by one investigator (SL) and validated by a secondary conductor (HD) to ensure accuracy of search and application of exclusion criteria. Risk of bias assessment Due to methodological issues regarding quality assessment of observational studies in epidemiology we assessed the quality of studies in eight specific domains that were relevant to the studies in question developed from Sanderson et al. [18] specifically to address issues with observational studies. Quality was assessed by risk of bias factors including: selection bias, measurement of outcome bias, assessor bias, completeness of data and data reporting, controlling for confounders, appropriateness of statistical analysis, and conflicts of interest. Quality assessment